Fannie Mae, Freddie Mac shares tumble after conservatorship comments
In a challenging market environment, Clorox Co (NYSE:CLX) stock has touched a 52-week low, dipping to $129.01. The household products giant, known for its bleach and cleaning supplies, has faced a turbulent year, with its stock price reflecting investor concerns over the company’s performance and broader economic pressures. According to InvestingPro analysis, the company appears undervalued at current levels, with a market capitalization of $16 billion and a P/E ratio of 23.2. Despite a modest 1-year change of -2.11%, the recent price level marks a significant point of interest for investors tracking the company’s resilience in a competitive sector. The company maintains a strong dividend profile with a current yield of 3.76% and has raised its dividend for 48 consecutive years, according to InvestingPro analysis. As Clorox navigates supply chain issues and changing consumer behaviors, the market will be watching closely to see if this 52-week low represents a temporary trough or a longer-term trend for the stock. For deeper insights, investors can access 10+ additional ProTips and a comprehensive Research Report covering Clorox’s financial health and growth prospects through InvestingPro.
In other recent news, Clorox reported fiscal third-quarter earnings that fell short of expectations, with earnings per share (EPS) of $1.45 missing the consensus estimate of $1.57. Organic sales declined by 2% year-over-year, influenced by reduced consumer consumption and retailer inventory cuts. Despite these challenges, Clorox’s gross margin increased by 240 basis points to 44.6%, surpassing expectations. The company adjusted its full-year 2025 sales growth forecast, factoring in a sales pullforward ahead of its ERP system transition. Analysts from Jefferies and JPMorgan revised their price targets for Clorox, with Jefferies lowering it to $167 while maintaining a Buy rating, and JPMorgan adjusting it to $144 with a Neutral rating. Wells Fargo (NYSE:WFC) also reduced its price target to $142, keeping an Equal Weight rating, citing uncertainty around Clorox’s business model and growth prospects. Additionally, Clorox announced the appointment of Gina Boswell, CEO of Bath & Body Works, to its board of directors, expanding the board to 12 members. The company’s market share remained stable despite concerns about increased promotional activity and consumer financial pressures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.